TECHNEUTRAL

TECH Debt-to-Equity Ratio Analysis

0.10x

Higher than 42% of Healthcare sector peers

Updated 29h ago·SEC filings & market data

Key Takeaway

The debt-to-equity ratio, or total debt divided by total shareholders' equity, is 0.10x, meaning debt equals 10% of equity.

Sector Performance

42th percentile

TECH

0.10x

Sector Median

0.26x

Sector Avg

0.89x

Prior Period

0.14x(May 2026)

↑ Improving
📊

Deep Analysis

The debt-to-equity ratio, or total debt divided by total shareholders' equity, is 0.10x, meaning debt equals 10% of equity.

This is below the Healthcare sector median of 0.45x, placing TECH in the 38th percentile among sector peers. The trend direction is N/A, with both year-over-year change and quarter-over-quarter change not available. The low debt level points to limited balance sheet risk, but the absence

Frequently Asked Questions

What does the Debt-to-Equity Ratio tell investors about TECH?

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

How is the Debt-to-Equity Ratio calculated?

Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.

How does TECH's Debt-to-Equity Ratio compare to its sector?

TECH's Debt-to-Equity Ratio of 0.10x compares to a Healthcare sector median of 0.26x, placing it in the 42th percentile.

Who are TECH's closest peers by Debt-to-Equity Ratio?

The closest Healthcare peers by Debt-to-Equity Ratio include: BIO (0.17x), BIIB (0.34x), NTLA (0.13x), BEAM (0.09x), RVTY (0.45x).

The Formula

Total Debt / Shareholders' Equity

Why It Matters

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

Advertisement

Master TECH's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full TECH research report

Free account — no credit card

TECH

0.10x

Sector Median

0.26x

Sector Avg

0.89x

How TECH's Debt-to-Equity Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.